Lv1
40 积分 2024-10-10 加入
Accounting for All Patients in Waterfall Plots
17天前
已关闭
Statistical Interpretation and Comparison of Waterfall Plots
17天前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
20天前
已完结
Exposure-Response Analyses Indicate a Promising Benefit/Risk Profile of Mosunetuzumab in Relapsed and Refractory Non-Hodgkin Lymphoma
22天前
已完结
Blinding in randomised trials: hiding who got what
29天前
已完结
Clinical response of immunotherapy targeting programmed cell death receptor 1/programmed cell death ligand 1 in advanced signet-ring-cell gastric cancer
1个月前
已完结
Domvanalimab combined with zimberelimab as first-line treatment in patients with PD-L1–high, advanced non-small cell lung cancer: Results from the randomized phase 2 ARC-10 study, Part 1
1个月前
已关闭
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
2个月前
已关闭
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
2个月前
已完结
Gastric cancer
2个月前
已完结
皖公网安备34019202002308
